Inventor · disambiguated record
Regina Heidenreich
Also filed as: HEIDENREICH REGINA
8 granted patents·17 pending applications·230 citations·filing 2015–2025
89Inventor score
Top patents by PatentIndex Score
25 records- 0198US10293058B2RNA containing composition for treatment of tumor diseasesCUREVAC AG·Filed 2016·Granted May 21, 2019·50 cites·16 claims
- 0297US11110166B2Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvantCUREVAC AG·Filed 2019·Granted Sep 7, 2021·32 cites·20 claims
- 0397US10918740B2RNA containing composition for treatment of tumor diseasesCUREVAC AG·Filed 2018·Granted Feb 16, 2021·38 cites·19 claims
- 0496US10869935B2RNA containing composition for treatment of tumor diseasesCUREVAC AG·Filed 2019·Granted Dec 22, 2020·29 cites·23 claims
- 0596US10369216B2Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvantCUREVAC AG·Filed 2015·Granted Aug 6, 2019·29 cites·17 claims
- 0694US10988754B2Nucleic acid moleculesCUREVAC AG·Filed 2018·Granted Apr 27, 2021·51 cites·21 claims
- 0791US12097253B2RSV RNA molecules and compositions for vaccinationCureVac SE·Filed 2024·Granted Sep 24, 2024·1 cites·45 claims
- 0884US12350330B2RSV RNA molecules and compositions for vaccinationCureVac SE·Filed 2024·Granted Jul 8, 2025·0 cites·42 claims
- 0981US2025213724A1Rna containing composition for treatment of tumor diseasesCureVac SE·Filed 2025·Application pending·0 cites
- 1081US2023338579A1Rna containing composition for treatment of tumor diseasesCureVac SE·Filed 2022·Application pending·0 cites
- 1178US2024101608A1Optimized nucleic acid moleculesCureVac SE·Filed 2023·Application pending·0 cites
- 1277US2025288522A1LIPID NANOPARTICLE mRNA VACCINESCureVac SE·Filed 2025·Application pending·0 cites
- 1370US2021361764A1Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvantCUREVAC AG·Filed 2021·Application pending·0 cites
- 1467US2021251898A1Lipid nanoparticle mrna vaccinesCUREVAC AG·Filed 2021·Application pending·0 cites
- 1564US2020163878A1Lipid nanoparticle mrna vaccinesCUREVAC AG·Filed 2017·Application pending·0 cites
- 1664US2020399322A1Optimized nucleic acid moleculesCUREVAC AG·Filed 2020·Application pending·0 cites
- 1763US2018207295A1Rna containing composition for treatment of tumor diseasesCUREVAC AG·Filed 2018·Application pending·0 cites
- 1862US2021170017A1Novel rsv rna molecules and compositions for vaccinationCUREVAC AG·Filed 2019·Application pending·0 cites
- 1960US2022396796A1Rna for cancer therapyCUREVAC AG·Filed 2022·Application pending·0 cites
- 2059US2021198649A1Novel nucleic acid moleculesCUREVAC AG·Filed 2021·Application pending·0 cites
- 2155US2018312545A1Optimized nucleic acid moleculesCUREVAC AG·Filed 2016·Application pending·0 cites
- 2248US2021361761A1Novel yellow fever nucleic acid molecules for vaccinationCUREVAC AG·Filed 2019·Application pending·0 cites
- 2347US2019185859A1Rna for cancer therapyCUREVAC AG·Filed 2017·Application pending·0 cites
- 2442US2020085944A1Rna vaccine and immune checkpoint inhibitors for combined anticancer therapyCUREVAC AG·Filed 2018·Application pending·0 cites
- 2540US2018296663A1Vaccine compositionCUREVAC AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Regina Heidenreich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →